Colin Pritchard, MD, PhD

Assistant Professor

University of Washington

Dr. Pritchard is an Assistant Professor of Laboratory Medicine, as well as the associate director of the genetics and solid tumors laboratory at the University of Washington Medical Center that services the Seattle Cancer Care Alliance (SCCA) that includes Seattle Children’s hospital. Dr. Pritchard undertook his undergraduate and graduate training at the University of Washington in Seattle in the United States. He completed his medical training at the University of Washington School of Medicine. The Pritchard laboratory focuses on oncology molecular diagnostics, particularly the source and utility of cell-free nucleic acid biomarkers in blood, and the development of innovative molecular diagnostics for the identification of mutations that can guide therapeutic decision-making. His clinical work focuses on applications of next-generation sequencing gene panels for cancer risk assessment and precision treatment. He has led the development and implementation of the ColoSeq™ Lynch and Polyposis Syndrome Panel and UW-OncoPlex™ Cancer Gene Panel in current clinical use for cancer patients and their families.

Danielle Castillo, BS

Senior Research Associate

Danielle Castillo, BS, is a Senior Research Associate in the Department of Clinical Cancer Genetics Molecular Laboratory at the City of Hope, where she assists Mr. Herzog in the maintenance of the Breast Cancer Registry, Hispanic Mutation Project, LiFTUP Project and other research endeavors. After spending a good part of her senior year working on water conservation at Stellenbosch University in Cape Town, South Africa Mrs. Castillo graduated with a bachelor’s degree in biology from Whittier College in 2008 Mrs. Castillo worked as a biologist for Irvine Scientific before coming to the City of Hope in early 2009.

Bita Nehoray, MS, CGC

Senior Genetic Counselor

City of Hope

Bita Nehoray, MS, CGC, is a licensed board-certified genetic counselor specializing in cancer genetics. She received her Master’s degree in Human Genetics and Genetic Counseling from Stanford University. Ms. Nehoray joined the City of Hope Division of Clinical Cancer Genomics in 2012, where she provides cancer genetics services for patients and families suspected to have a hereditary predisposition to cancer, with a focus in Li-Fraumeni syndrome. She is fluent in Spanish and Farsi and is committed to advancing the provision of cancer genetics services to medically underserved and culturally diverse populations. Other clinical responsibilities include providing pro-bono cancer genetic counseling services to underserved Latino families through an outreach program established by the Division of Clinical Cancer Genomics and supported through government and foundations grants and compassionate funding. Current research projects include understanding cancer risk, penetrance, prevalence, and clinical outcomes for individuals with TP53 mutations as part of the LiFT Up study, evaluating the spectrum of germline variants in Israeli breast cancer patients, and assessing Community-based provider experiences with polygenic risk scores in genetic cancer risk assessment. She serves on the Genetic Counseling Advisory Committee for the Li-Fraumeni Syndrome Association. She is an active member of the National Society of Genetic Counselors, Southern California Genetic Counselors, and the American Society of Human Genetics.

Components visible upon registration.